AI Health & Biotechnology

New AI Blood Test Detects Multiple Brain Diseases

Researchers at Lund University developed ProtAIDe-Dx to identify Alzheimer's, Parkinson's, and ALS in one sample.

By Kronos News Desk··1 min read
A close-up of a medical blood sample vial in a laboratory, with a digital interface showing AI-driven diagnostic data in the background.

A close-up of a medical blood sample vial in a laboratory, with a digital interface showing AI-driven diagnostic data in the background.

Photo: Kronos News

Researchers at Lund University have developed a new artificial intelligence model called ProtAIDe-Dx [1]. This tool can identify multiple neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS, using a single blood sample [2]. The findings were recently published in the journal Nature Medicine [1]. The system uses proteomics to analyze complex protein patterns within the blood [2]. This approach offers a faster and less invasive alternative to traditional diagnostic methods like brain imaging or spinal taps [3]. Experts suggest this could significantly lower the cost of screening for brain disorders [1]. Early detection is critical for managing these conditions and planning treatments [3]. ProtAIDe-Dx aims to streamline the clinical process by checking for several conditions at once [2]. This technology may help doctors diagnose patients earlier than current diagnostic tools allow [3].

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Under review

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

A concise briefing with selected stories and analysis.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Kronos News Desk covers ai health & biotechnology and editorial analysis for Kronos News.